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Hypoxia of the kidney in diabetes could predispose it to
develop acute and chronic renal failure. To examine the
relationship between renal hypoxia and renal failure, we
measured hypoxia (as a pimonidazole adducts), hypoxia-
inducible factors (HIFs), and a hypoxia target gene heme
oxygenase-1. The studies were performed in rats with
streptozotocin (STZ)-induced diabetes, Cohen diabetes
sensitive rats, and during short-term artificial hyperglycemia
in rats induced by intravenous glucose and octreotide.
STZ-treated rats received insulin, the superoxide dismutase
mimetic tempol, or contrast medium. Radiocontrast media
causes hypoxia and HIF induction. Hypoxia, HIFs, and heme
oxygenase were undetectable in controls, but transiently
activated in STZ-treated and the Cohen diabetes sensitive
rats. Different patterns of HIFs and pimonidazole were
observed between the three models. Insulin abolished
pimonidazole and HIF induction, whereas tempol lead to
increased HIFs and heme oxygenase induction at similar
levels of pimonidazole. When compared with control rats,
STZ-treated rats exhibited more intense and protracted renal
pimonidazole, with augmented hypoxia inducible factor
production and reduced GFR following contrast media.
Our data suggest that both regional hypoxia and hypoxia
adaptation transiently occur in early stages of experimental
diabetes, largely dependent on hyperglycemia or after
contrast media. Tempol may augment the HIF response
in diabetes.
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To our knowledge, there is no generally accepted definition of
hypoxia. Hochachka et al.1 have nicely reviewed how cells
reduce their ATP production and consumption, when ‘oxygen
availability becomes limiting’, a paraphrase of the term
‘hypoxia’. Obviously, they understand ‘hypoxia’ as a condition
which elicits either cell damage or specific adaptational
responses, termed ‘hypoxia adaptation’. In this study hypoxia
is considered as a pathologic condition of mismatch between
oxygen supply and consumption. Accordingly, in the normal
kidney, oxygen homeostasis would be preserved. This would be
in line with the fact that in our hands the hypoxia detection
tools employed in this study, namely pimonidazole adducts
(PIM) and hypoxia-inducible factors (HIFs), are hardly
detectable or undetectable in normal kidneys, despite known
low pO2 within the renal medulla.
Recently, using oxygen microelectrodes, Palm et al.2 found
that renal tissue pO2 is substantially lower in diabetic rats, as
compared with control (CTR) animals. Using blood oxygen
level-dependent magnetic resonance imaging Ries et al.3 have
shown that deoxyhemoglobin signals rose in the diabetic
kidney, particularly in the outer medullary region. Intrarenal
microcirculation was not altered,2 whereas oxygen consump-
tion ex vivo by cortical and medullary tubular cells was
significantly enhanced.2 Taken together these data suggest
that the diabetic kidney is more likely to develop hypoxia.
Increasing evidence suggests that regional renal hypoxia
plays an important pathophysiologic role in acute kidney
injury (AKI), irrespective of the underlying cause.4,5
Furthermore, chronic hypoxia seems to play an important
role in the progression of chronic renal failure.6 Thus,
evaluation of renal hypoxia could be important for the
understanding of AKI and CRF in diabetes. Indeed, diabetes
is a major risk factor for the development of specific subsets
of AKI, namely papillary necrosis,7 contrast nephropathy,8,9
and or following cardiac bypass operations,10,11 and is
becoming the leading cause of end-stage kidney disease in
developed countries.12
Hypoxia adaptation takes place within the kidney,
conferred through HIFs. HIFs are heterodimers composed of a
constitutive b-subunit and one of at least two different
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oxygen-dependent a-subunits. Regulation of HIF mainly occurs
by oxygen-dependent proteolysis of the a-subunit. HIFs govern
transcriptional activity of a host of genes, many of which are
cell/tissue protective.13–16 Yet, HIF may also exert adverse
responses, such as the aggravation of diabetic retinopathy
through the induction of vascular endothelial growth factor.17
HIF activity can be modulated by a number of factors,
among which are reactive oxygen species (ROS) like
hydrogen peroxide and superoxide (O2
).18–21 Diabetes leads
to increased production of ROS.22 In the renal medulla, thick
ascending limbs of the loop of Henle (TALs) produce O2
 due
to increased NAD(P)H oxidase activity.23 O2
 has been shown
to induce renal vascular constriction,24 to enhance tubular
salt reabsorption,25 and reduce HIF activity.26 Hence, O2

may both intensify renal medullary hypoxia and reduce
hypoxia adaptation in diabetes. The soluble cell membrane-
permeable superoxide dismutase mimetic tempol has been
shown to reduce O2
 levels in vivo,27 but its effect on renal
medullary hypoxia has not been assessed in diabetes, so far.
The cell-protective effect of the HIF target gene heme
oxygenase-1 (HO-1) relies, at least partly, on its ROS
scavenging ability.28 Therefore, HO-1 activation may protect
from diabetes-induced renal injury.
This study was designed to explore the cellular and
temporal distribution and the underlying mechanisms of
renal hypoxia in experimental diabetes, to identify potential
hypoxia adaptation, and to assess the possible relationship
between renal hypoxia and susceptibility to AKI in diabetes.
RESULTS
Functional parameters after induction of diabetes
Rats with streptozotocin (STZ)-induced diabetes developed
both fasting and postprandial (PP) hyperglycemia (Glc)
within 2 days (393735 mg dl1) as compared with
8872 mg dl1 in CTRs) (Table 1). Plasma insulin
(3775 mU ml1 in CTR) determined at 2, 7, and 14 days of
STZ was significantly reduced to 1872 mU ml1, 2172, and
2571 mU ml1 (n¼ 4 per group, Po0.01 vs CTR). At 14–90
days of STZ, kidney/body weight ratio, urine volume, plasma
urea, kaliuresis, and weight-adjusted creatinine clearance
were all significantly elevated, whereas animal weight and
tubular sodium reabsorption were significantly depressed.
Cohen diabetes sensitive rats (CDS rats) kept on a
diabetogenic diet for 30 days had normal fasting glucose,
but prolonged PP hyperglycemia (Glc). When compared with
rats 30 days after STZ, animal weight was higher, whereas
weight-adjusted creatinine clearance, PP glycemia, and urine
volume were lower.
PIM, HIFs, and HO-1 transiently occur in diabetic rats
PIM were detectable as early as 7 days after STZ injection,
increased at 14 and 30 days (papilla and inner stripe of the
outer medulla), but were no longer present at 90 days.
Potential hypoxia-adaptive response, manifested by HIF and
HO-1 expression, closely followed; PIM, HIF-1a, HIF-2a,
and the HIF target gene HO-1 all located in the same renal
zones, mostly within 2 to 5 tubular diameters distance
(Figures 1 and 2; Table 2). Noteworthy, most likely HIFs and
PIM have different kinetics and different hypoxia thresholds,
and activation of HIF target gene products occurs with a
delay of several hours. Not surprisingly, PIM, HIF, and HO-1
signals showed only partial overlap at the cellular level, as has
been observed in previous studies.29–31 Evidence of hypoxia
was confined to the inner stripe of the outer medulla
(Figure 1) and the papilla (Figure 2). As previously described
in other experimental models,29–31 HIF-1a appeared in
Table 1 | Functional changes in diabetic rats
CTR-2
(7 days)
(n=11)
STZ
(2 days)
(n=8)a
STZ
(7 days)
(n=8)a
CTR-14–30
days
(n=46)
STZ
(14 days)
(n=35)b
STZ
(30 days)
(n=7)b
CTR(90
days)
(n=9)
STZ
(90 days)
(n=8)c
CDS-rats
(30 days)
(n=10)d
Body weight (g) 28078 291720 248712e 34573 268717f 231724f 40675 23479f 23577
Two kidney weight (g) 3.070.1 3.370.3 2.970.1 3.170.1 3.670.2g 3.770.4 3.770.2 3.570.1 2.670.1g
Kidney/body
weight (%)
0.970.0 1.070.0 1.070.0 0.970.0 1.270.1g 1.670.1f 0.970.0 1.670.1f 1.170.0f
Blood glucose
(mg dl1)
8872 393735f 384722f 9173 394711f 380729f 8776 415726f 252733g
Urine volume (ml h1) 0.570.0 ND ND 0.570.0 5.570.4f 3.470.7f 0.670.1 3.370.4f 0.770.1f
PCr (mmol l1) 5375 ND ND 5171 4972 4673 5170 3873e 5572e
P-urea (mmo /l1) 7.070.2 ND ND 6.670.2 11.070.8f 16.975.3f 7.370.5 14.972.3f 6.070.6e
ClCr (ml min
1) 1.170.1 ND ND 1.570.1 1.970.1e 1.870.4 1.570.3 1.470.1 0.670.3g
(ml min1 100 g1) 0.470.0 0.470.0 0.670.0f 0.870.2f 0.470.1 0.670.1e 0.370.0g
TRNa (%) 99.570.0 ND ND 99.770.1 99.070.1f 99.170.2e 99.570.1 99.070.3g 96.972.7
FEK (%) 16.578.5 ND ND 9.371.1 38.771.7f 21.474.1e 11.373.9 24.874.4g 21.272.1
CDS rats, Cohen diabetes sensitive rats; ClCr, creatinine clearance; CTR, control; FEK, fractional potassium excretion; ND, not determined; PCr, plasma creatinine;
STZ, streptozotocin; TRNa, tubular sodium reabsorption.
aTested vs CTR-2–7 days.
bTested vs CTR-14–30 days.
cTested vs CTR-90 days.
dTested vs STZ-30 days.
ePo0.05.
fPo0.001 vs respective control group, 1-way ANOVA.
gPo0.01.
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tubules and in papillary interstitial cells, whereas HIF-2a
exclusively located in non-epithelial cells (Figures 1 and 2). In
the inner stripe of the outer medulla, HIF-1a signals
were present in both medullary thick ascending limbs
(mTALs) and collecting ducts (CDs) (Figure 1d). This
pattern of tubular HIF-1a expression contrasts with previous
studies, using different hypoxic stimuli, in which HIF-1a
has almost exclusively been detected in CDs in this particular
renal zone.29–32 HO-1 appeared in outer medullary interstitial
cells (Figure 1j). Signal density/intensity increased toward
the mid-inter-bundle zone (away from oxygen supplying
vasa recta, not shown), suggesting hypoxic induction of
HO-1.
Since STZ rats conceivably was hypovolemic, a condition
that per se can induce renal hypoxia,33 additional animals
received fluids at 14 days of STZ, but the HIF/PIM/HO-1
signals remained unaffected (Table 2). Moreover, in CDS rats,
in which fluid balance was better maintained, the signals for
PIM, HIFs, and HO-1 were of similar distribution and extent
as in STZ (Table 3).
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Figure 1 | PIM, HIFs and HO-1 in the inner stripe of the outer medulla in STZ-induced diabetes. Immunohistochemistry for the hypoxia
marker pimonidazole (PIM), HIF-1a, HIF-2a, and the HIF target gene HO-1; asterisk¼ thick ascending limb (TAL), CD¼ collecting duct;
arrow¼ endothelial cell; arrowhead¼ interstitial cell; STZ¼ streptozotocin, VB¼ vascular bundles. Rats were studied at 14 days of STZ. No
signals for either marker were detected in non-diabetic CTRs (not shown). PIM occurred in TALs and to a lesser extent in CDs, increasing
with distance from VBs (a). HIF-1a appeared in CDs and TALs (d), whereas HIF-2a appeared in capillary endothelial cells and in the
interstitial cells of the inter-bundle zone (g). The HIF target gene HO-1 was detected in interstitial cells (j). Two days of insulin treatment
abolished renal PIM and HIFs (b, e, h, k). Twelve days of treatment with the superoxide dismutase mimetic tempol had no major effect
on PIM (c), but HIF-1a (f), HIF-2a (i), and HO-1 (l) were increased. Magnifications: (a–c),  440; (d–l),  600.
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PIM and HIF-2 are activated in artificial hyperglycemia
To test whether hyperglycemia per se augments renal medul-
lary PIM and activates HIF, we induced artificial hyper-
glycemia (Glc) in three CTR rats, with the help of glucose
and octreotide infusion, and determined hypoxia markers
after 2 h of sustained Glc (380–465 mg dl1). Indeed, PIM was
detectable in the papillary interstitium (Figure 3). This
pattern differed from that observed in both STZ and CDS
rats. In the latter two both interstitial and tubular elements
stained for PIMs. Noteworthy, in Glc tubular compartments
were HIF-1a negative. By contrast, HIF-2a appeared in
endothelial cells in all renal zones (Table 3).
Insulin treatment abolishes PIM and HIFs in STZ
To test whether glycemic CTR could ameliorate renal
hypoxia, additional animals received insulin implants at
12–14 days of STZ, with fasting glucose declining to
5578 mg dl1. Kidneys were negative for either PIM or
HIFs, suggesting that oxygen homeostasis had been restored
(Figures 1 and 2; Table 2).
Tempol has no major impact on renal PIM, but enhances HIFs
and HO-1 in STZ
To determine the possible contribution of O2
 (which is
increased in diabetic kidneys22) to the genesis of renal
medullary hypoxia, the soluble superoxide dismutase mi-
metic, tempol, was delivered to STZ rats from 2–14 days after
the induction of diabetes. Tempol lead to a statistically non-
significant trend (P¼ 0.075) for less PIM in the inner stripe
of the outer medulla (Figure 1; Table 2), or in the papilla
(Table 2). Tempol markedly increased HIF-1a, HIF-2a, and
the HIF target gene HO-1 in the inner stripe of the outer
medulla (but not in the papilla, not shown; Figure 1; Table 2).
Diabetes enhances contrast medium-induced renal medul-
lary PIM and HIFs
Since renal medullary PIM and HIFa activation,29 as well as
enhanced deoxyhemoglobin,34 have been shown at 2 h after
the injection of contrast medium (CM) in CTR rats, we
sought to examine whether CM would intensify PIM and
HIFs in diabetic kidneys. In addition, since diabetes
predisposes to CM-induced nephropathy,8,9 we determined
renal function and tubular damage (in 1 mm semi-thin plastic
sections) at 24 h after CM. Diabetic animals used in these
studies were at 14 days of STZ. No major tubular damage was
evident in either experimental group, but creatinine clearance
significantly dropped in STZ, while being stable in CTR
(Table 4).
Moreover, the extent and time course of PIM and HIFs
appearance were different between CTR and diabetic rats
(Table 5). In CTR rats PIM transiently occurred at 1 h, being
undetectable at baseline and at 2 h, respectively. HIFs were
absent at baseline, upregulated at 1 h, and less prominent but
still detectable at 2 h. By contrast, in STZ both PIM and HIFs
were already evident at baseline, markedly intensified at 1 h,
and sustained at 2 h. Our results suggest that in diabetes,
CM-induced renal medullary hypoxia is intensified and
protracted.
To exclude that the functional changes observed after CM
were, at least partly, caused by STZ nephrotoxicity (which has
been reported up to 3 weeks after its administration35), we
injected CM at 30 days of STZ (n¼ 8), as well as in age-
matched CTRs (n¼ 8). Again, in STZ, creatinine clearance
significantly dropped (0.6670.17 mg ml1  100 g at baseline
vs 0.4570.09 mg ml1  100 g at 1 day, Po0.05), whereas
it remained stable in CTR (0.3370.03 mg ml1  100 g at
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Figure 2 | PIM and HIFs in the papilla in STZ-induced diabetes.
Immunohistochemistry for the hypoxia marker pimonidazole (PIM),
HIF-1a, and HIF-2a; CD¼ unstained collecting duct; CD¼ stained
collecting duct; arrowhead¼ interstitial cell; STZ¼ streptozotocin.
Rats were studied at 14 days of STZ. No signals for either marker were
detected in non-diabetic CTRs (not shown). PIM occurred in all
cellular compartments in the core of the papilla (upper portion in a).
However, toward the papillary tip (lower portion in a), CDs became
negative for PIM, whereas some interstitial staining was preserved.
HIF-1a mainly appeared in CDs and interstitial cells (c), whereas
HIF-2a mainly appeared in interstitial cells (e). Two days of insulin
treatment abolished renal papillary PIM and HIFs (b, d, f).
Magnifications: (a, b),  440; (c–f),  600.
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baseline vs 0.3270.02 mg ml1  100 g at 1 day). Rare focal
mTAL damage (o1% of tubules in the mid-inner stripe) was
noted in 2/8 of the diabetic animals but not in the CTR group.
DISCUSSION
This study reveals following five main findings: first, renal
medullary PIM and HIFs occur in experimental models of
insulin-deficient diabetes, suggesting renal hypoxia; second,
diabetic renal hypoxia likely is dependent on Glc, since it is
prevented by short-term insulin treatment; third, diabetes
and artificial Glc elicit different renal hypoxia patterns,
suggesting a contribution of diabetes-induced morpho-
functional changes to renal hypoxia; fourth, the superoxide
dismutase mimetic tempol enhances HIFs and the HIF target
gene HO-1 in diabetes; and fifth, after CM, diabetic renal
medullary PIM and HIFs are enhanced, suggesting intensified
and protracted hypoxia.
To our knowledge, this is the first immunohistochemical
report of both PIM and HIFs in the diabetic kidney.
Using PIM immunostaining, we confirm a reduced oxygen
content in the diabetic renal medulla, previously shown by
oxygen electrode and blood oxygen level-dependent magnetic
resonance imaging measurements in STZ diabetes.2,3 We
validate these findings, eliminating a possible effect of STZ
itself, showing a similar pattern of distribution of PIM
adducts in CDS rats. Our results further suggest that a
pathologic hypoxic condition (hence termed ‘hypoxia’ for
simplicity) occurs in the diabetic renal medulla, since HIFs
and HO-1 are activated, indicating hypoxia adaptation. This
study extends previous data by assigning hypoxia and
potential hypoxia adaptation to particular cellular elements.
Possible mechanisms of diabetes-induced renal hypoxia
The mechanism(s) responsible for the transient occurrence of
renal hypoxia in early experimental diabetes most likely
relates to increased tubular oxygen consumption for salt
reabsorption. Consistent with mTAL workload being a major
determinant of outer medullary oxygenation,36 PIM was
mostly detected in mTALs. Moreover, insulin treatment,
which abolished hypoxia markers in this study, could have
reduced tubular workload both by glomerular filtration rate
reduction37 and the amelioration of osmotic diuresis. The
latter mechanism has been shown to reduce early distal
tubular NaCl content, which is consistent with increased
sodium reabsorption of the preceding nephron segments.38
Short-term (2 h) Glc was sufficient to induce the
‘complete’ PIM/HIF pattern in CDS rats (which have normal
fasting blood glucose and were studied at 2 h after food
intake). But 2 h of artificial Glc in Sprague–Dawley (SD) rats
produced a different and somehow ‘incomplete’ PIM/HIF
pattern, when compared with STZ/CDS rats. Most likely,
morpho-functional changes (e.g., tubular hypertrophy,
Table 2 | PIM, HIFs, and HO-1 in experimental diabetes along time (inner stripe of the outer medulla)
STZ
14 days
CDS rats
CTR 2 days 7 days +tempol +insulin +fluid 30 days 90 days 30 days
n 5 4 4 13 5 7 3 6 4 5
PIM 0 0 0.770.3 2.370.2a 1.670.2 0.370.2b 2.070.0 2.070.0a 0 2.070.3
HIF-1a 0 0 0.570.3 1.870.2a 3.270.4b 0.470.2b 2.070.0 2.070.3a 0 2.270.4
HIF-2a 0 0 0.570.3 1.870.2a 2.870.2c 0.370.2b 1.770.3 1.670.2a 0 1.870.2
HO-1 0 0 1.070.4d 1.970.2a 3.270.8e 0.470.2b 1.770.3 1.670.2a 0 1.470.2
CTR, non-diabetic control; CDS rats, Cohen diabetes sensitive rats; HIF, hypoxia-inducible factor; HO-1, heme oxygenase-1; PIM, pimonidazole adduct; STZ, streptozotocin.
Semiquantitative immunohistochemical staining: 0, no signals detectable; 1+, staining in o5% of tubular profiles or interstitial/endothelial cells; 2+, 5–20%; 3+, 20–33%.
Irrespective of the experimental condition, location of signals followed the same renal zone-specific pattern (see Table 4).
aPo0.001.
bPo0.001.
cPo0.01.
dPo0.05, vs CTR.
ePo0.05 vs STZ 14 days, ANOVA.
Table 3 | Different location of PIM, HIFs, and HO-1 in experimental diabetes vs artificial Glc
Pimonidazole HIF-1a HIF-2a
Diabetes STZ
(14 days)
Artificial
hyperglycemia
Diabetes STZ
(14 days)
Artificial
hyper-glycemia
Diabetes STZ
(14 days)
Artificial
hyper-glycemia
Cortex — — — — — ECg, ECti
Outer stripe — — — — — ECti
Inner stripe TAL — TAL
CD
— ECti, IC ECvb
Papilla CD, IC, EC, ECM IC (ECM) CD, IC — EC, IC EC (IC)
CD, collecting duct; EC, endothelial cell; ECg, glomerular EC; ECti, tubulo-interstitial EC; ECvb, vascular bundle EC; ECM, extracellular matrix; Glc, hyperglycemia; HIF, hypoxia-
inducible factor; IC, interstitial cell; inner stripe, inner stripe of the outer medulla; outer stripe, outer stripe of the outer medulla; STZ, streptozotocin; TAL, thick ascending limb.
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altered salt handling), which occur in STZ/CDS rats were
responsible for this difference.
Factors which less likely had caused diabetic renal hypoxia
include direct STZ toxicity35 and hypovolemia.33 Hypoxia
developed over time in STZ and also occurred in CDS rats.
Fluids had no impact on renal HIFs and PIM.
Declining tubular transport activity may explain the
disappearance of PIM/HIF at 90 days of STZ. Noteworthy,
in STZ, mTAL Na/K-ATPase activity (which may be
considered a surrogate marker of oxygen consumption) is
markedly increased at 35 days,39 and normalizes or is even
subnormal at 90 days39,40, which well parallels the time course
of renal hypoxia described in this study.
a b
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Figure 3 | Renal PIM and HIF-2a induced by artificial Glc.
Immunohistochemistry for the hypoxia marker pimonidazole (PIM)
and HIF-2a; arrow¼ endothelial cell and CD¼ collecting duct. Normal
rats were studied after 2 h of artificial Glc. No signals for either marker
were detected in CTRs, and no HIF-1a signals were detected in Glc
(not shown). Throughout the renal zones endothelial cells expressed
HIF-2a. In the cortex, glomeruli (a) and tubulointerstitial capillaries
(b) stained positive. In the outer medulla, tubulointerstitial capillaries
expressed HIF-2a only in the outer stripe (c). By contrast, in the
inner stripe, vascular bundles intensely stained for HIF-2a, but the
inter-bundle zone was void of signals (not shown). PIM, which
only accumulate in deeply hypoxic tissue, were confined to the
papillary interstitium (e; note that CDs are not stained). Accordingly,
HIF-2a was also expressed in the papilla (f). Magnification:  1000.
Table 4 | Changes at 24 h after delivery of CM to CTR and
diabetic (14 days after STZ) rats
Controls+CM
(n=7)
Diabetes
(STZ 14 days)+CM
(n=6)
Animal weight (g) 33977 297714a
Blood glucose (mg dl1) 8673 421731b
Urine volume
0 day (ml h1) 0.6470.11 6.9571.04b
1 day 0.7670.07 4.9570.07b,c
PCr
0 day (mmol l1) 5373 4573
1 day 6174 5273
ClCr
0 day (ml min1) 1.2970.15 2.6170.10a
1 day 1.3570.12 1.3870.26c
ClCrper 100 g
0 day (ml min1) 0.3770.05 0.8370.04d
1 day 0.3970.03 0.4570.08c
P-urea
0 day (mmol l1) 6.770.5 13.772.1d
1 day 8.672.1 12.472.5
TRNa
0 day (%) 99.5370.13 98.9770.14a
1 day 99.8270.03 98.5870.69
FEK
0 day (%) 13.172.2 35.572.8b
1 day 13.872.0 44.9710.4a
ClCr, creatinine clearance; CM, contrast medium; CTR, control; FEK, fractional
potassium excretion; PCr, plasma creatinine; STZ, streptozotocin; TRNa, tubular
sodium reabsorption.
The effect of acute hypoxic insults on kidney function in controls (CTRs) and at
14 days of STZ. Both groups were subjected to meglumine iothalamate 8 ml kg1.
aPo0.05.
bPo0.001 vs CTR.
cPo0.05 vs baseline, non-paired, and paired t-test, respectively.
dPo0.01.
Table 5 | Renal papillary PIM, HIFs, and HO-1 at 1 and 2 h after
delivery of contrast medium to CTR or diabetic (14 days of
STZ) rats
Control Diabetes (STZ 14 days)
Untreated
CM
(1 h)
CM
(2 h) Untreated
CM
(1 h)
CM
(2 h)
n= 5 3 9 13 3 9
Pimonidazole 0 2.070.0a 0.370.3 1.770.3a 3.370.3b 2.770.3b
HIF-1a 0 1.770.3a 0.970.2 1.570.2a 3.070.6b 2.870.2b
HIF-2a 0 1.770.3a 0.770.2 1.470.2a 3.370.3c 2.870.3d
CM, radiocontrast medium; CTR, control; HIF, hypoxia-inducible factor; STZ,
streptozotocin.
Semiquantitative immunohistochemical staining: 0, no signals detectable; 1+,
staining in o5% of tubular profiles or interstitial/endothelial cells; 2+, 5–20%; 3+,
20–33%; 4+, 33–50%. In both control and diabetic animals, location of signals
followed the same renal zone-specific pattern described in Table 3.
aPo0.01 vs untreated controls.
bPo0.001.
cPo0.01.
dPo0.05 vs untreated diabetics, ANOVA.
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Different hypoxia patterns in diabetes and artificial Glc
As mentioned above, Glc lead to renal PIM/HIF appearance,
albeit with a pattern largely different from STZ/CDS rats. In
the latter PIM/HIFs mainly located in the inter-bundle zone
of the inner stripe, at the site of high tubular reabsorptive
activity, suggesting a major contribution of tubular workload.
By contrast, Glc seems to primarily induce endothelial stress,
since vascular bundles of the inner stripe intensely stained for
HIF-2a, but no signals were detectable in the inter-bundle
zone. We have no explanation for this particular distribution
of HIF-2a immunoreactivity, that might be triggered by
factors other than hypoxia per se, as previously shown by
studies in cell cultures kept under 21% ambient oxygen.41,42
However, such normoxic HIF activation would take much
longer than 2 h, since it is based on enhanced HIFa
transcription/translation. By contrast, hypoxic HIF activation
through blockade of HIFa proteolysis is almost instanta-
neous. Moreover, PIM adducts shown in the papilla during
Glc indicate that, indeed, hypoxia played a role in endothelial
HIF activation.
Tempol augments hypoxia response in vivo
Generation of O2
 is an attractive explanation for diabetes-
induced renal hypoxia, since O2
 is activated in diabetes,22
promotes renal medullary vasoconstriction,24 and enhances
tubular reabsorptive activity.25 In this study there was a trend
(P¼ 0.075) for reduced PIM staining with tempol, which
with a higher N (number of animals) might have reached
statistical significance.
The impact of ROS on HIF activity is a matter of debate,
given that in vitro studies have provided conflicting
results.18–21 Yang et al.26 have shown that O2
 reduces HIF-
1a and its target gene HO-1 in renal medullary interstitial
cells, which could be prevented by tempol. Katavetin et al.43
demonstrated that D-glucose blunted the hypoxia response in
immortalized rat proximal tubular cells, which could be
prevented by the radical scavenger a-tocopherol. Zou and
Cowley21 have nicely reviewed the current knowledge about
HIF/O22interaction, supporting the view that O2 reduces
hypoxic HIF activation, probably through an increased
proteasomal degradation of HIFa. To our knowledge, the
impact of ROS on HIF has not been addressed in vivo, so far.
In concordance with the view of Zou and Cowley we show
that tempol augments HIFs and HO-1 in vivo in the diabetic
renal medulla, suggesting that local production of O2
 may
have suppressed HIFs.
CM aggravates renal hypoxia in diabetes
Diabetics are prone to develop CM-induced AKI,8,9 but
the underlying mechanisms are largely unknown. Hypoxia
has been proposed as a unifying hypothesis in AKI, and
particularly so in radiocontrast nephropathy.29,34 In support
of this view, we show for the first time that CM leads to
intensified and protracted renal hypoxia in diabetic rats.
Moreover, we demonstrate that, at least in early stages of
diabetes, CM also enhances renal HIFs, suggesting hypoxia
adaptation. Such adaptive responses may, at least partly,
explain that in our study morphology was preserved at 24 h
after CM, despite some functional impairment. One could
speculate that in more advanced experimental or human
diabetic nephropathy, the potential for hypoxia adaptation
would be reduced, and consequently, overt CM-induced cell
damage would occur.
CONCLUSIONS
Experimental diabetes leads to transient renal medullary
hypoxia, which is largely dependent on Glc. Intensified and
protracted hypoxia following CM is a possible explanation
for the propensity to CM-induced AKI in diabetes. Never-
theless, diabetic kidneys hold a potential for HIF-mediated
cell protection, and its enhancement might be a logical
therapeutic strategy in the prevention of AKI and in
ameliorating the progression of tubulointerstitial disease in
the diabetic kidney.
MATERIALS AND METHODS
Animals and materials
Male SD rats (250–350 g) were used for the STZ model (of insulin-
deficient diabetes with both fasting and PP Glc) and artificial Glc
studies detailed below, fed regular chow and with free access to
water. Inbred CDS rats were used as an attenuated model of insulin
deficient diabetes, with normal fasting insulin and blood glucose
levels, but protracted PP Glc due to deficient b-cell response.44,45
Chemicals were purchased from Sigma (St Louis, MO), if not
stated otherwise. Experiments were conducted in accordance with
the NIH Guidelines for the Care and Use of Laboratory Animals.
Experimental groups
STZ-induced diabetic rats, a model of partial type I diabetes: SD
rats received a single intraperitoneal injection of freshly prepared
STZ (65 mg kg1 body weight, dissolved in 100 mmol l1 citric
acid, pH 4.5), and confirmed 2 days later by PP blood glucose
(4250 mg dl1).
CTR rats: Vehicle-injected SD rats after 2 to 7 days, 14 to 30 days,
and 90 days served as CTR for the 2 and 7 days STZ, the 14 and 30
days STZ, and for the 90 days STZ, respectively.
Insulin treatment in STZ: Glc was normalized in seven animals
during 12–14 days of STZ by subcutaneous insulin implants
(2U day1; Lin Shin Canada, Ontario, Canada).
Anti-oxidant treatment in STZ: According to Li46 the soluble
superoxide dismutase mimetic 4-hydroxyl-tetramethylpiperidin-
oxyl (tempol, kindly provided by Haj Yechia47) was added to
drinking water (about 120 mg kg1 day1) from 2 to 14 days of STZ.
Fluid replacement: 14-day STZ diabetic rats were given two 4 ml
saline injections intraperitoneally, 1 h apart, and were killed 1 h later
for immunohistochemistry. PIM was injected intravenously con-
comitantly with the second intraperitoneal fluid load.
CDS model: CDS rats 6- to 8-week old, initially weighing
240–280 g, were studied after an interval of 30 days on a special
copper-free diabetogenic diet (18% casein, 72% sucrose, 4.5%
butter, 0.5% corn oil, 5% salt No II USP, and fat-soluble vitamins,
distilled water ad libitum). Of note, this diet is a prerequisite for the
development of the diabetic phenotype, characterized by normal
fasting glucose but protracted PP Glc.44,45 Animals were trained to
eat in the morning, and assessment of glycemia and renal harvesting
40 Kidney International (2008) 73, 34–42
o r i g i n a l a r t i c l e C Rosenberger et al.: Hypoxia adaptation in rat kidney
for immunostaining were carried out 2–3 h after a documented
morning snack.
Short-term artificial hyperglycemia (Glc): hyperglycemia (Glc)
(4250 mg dl1) was induced in SD rats according to the procedure
described by Lien;48 inactin anesthesia (100 mg kg1), intravenous
infusion of 10% glucose coupled with the somatostatin analogue
octreotide (Sandoz Pharma, Basel, Switzerland; 10 mg bolus followed
by 1 mg min1 infusion). Glc was maintained for 2 h and validated at
30-min intervals.
CM-induced acute renal hypoxia in CTR and at 14 and 30 days of
STZ: In a separate set of experiments, following a baseline period in
metabolic cages, under anesthesia (ketamine 100 mg kg1 intraper-
itoneally) the femoral artery was cannulated with a polyethylene tube
(PE-50; Clay-Adams, Parsippany, NJ), and the animals were subjected
to the CM meglumine iothalamate (Conray 60%; Mallinckrodt, St
Louis, MO; 6 ml kg1 intra-arterial). The vascular catheters were
removed and the rats were killed for immunohistochemistry at 1 or 2 h
later (only at 14 days of STZ), or were allowed to recover in metabolic
cages and killed 24 h later for renal morphology or immunohisto-
chemistry. Mortality (by 24 h) among STZ and CTR subjected to CM
was 2 and 0%, respectively. CTR groups used in these series were
weight-matched for the 14-day period (to ensure comparable
radiocontrast volume) and age-matched for the 30-day period.
Functional studies and the renal perfusion fixation technique
Rats were kept in metabolic cages (Nalge, Rochester, NY) for 24 h.
Under pentobarbital anesthesia (60 mg kg1) the kidneys were
perfusion-fixed selectively through the abdominal aorta, with
1.25% glutaraldehyde (for semi-thin sections) or with 3%
paraformaldehyde (for immunohistochemical studies), as previously
detailed.30,49 The weight of the two kidneys was determined
following the fixation perfusion. Plasma and urine samples were
processed for the determination of creatinine, urea, sodium, and
potassium, and creatinine clearance, fractional sodium reabsorption,
and potassium excretion were calculated.
Determination of renal morphology
Kidney slices were postfixed in buffered 2% OsO4, dehydrated, and
embedded in an Araldite-EM bed 812 mixture. Large sections were
cut perpendicular to the renal capsule, containing cortex, and
medulla. Thin (1mm) sections were analyzed in a blinded manner
for morphologic alterations, as previously detailed.49
Determination of renal parenchymal hypoxia and potential
hypoxia adaptation
Renal hypoxia and hypoxia adaptation were assessed by immuno-
staining for pimonidazole (Hypoxyprobe, Pharmacia International,
Belmont, MA; PIM), HIFs, and heme-oxygenase-1 (HO-1).29,30
PIM, which binds to tissues with pO2 levels below 10 mm Hg,
50,51
was injected in vivo (60 mg kg1 intravenously) 1 h before the
kidneys were perfusion fixed. The following primary antibodies were
used as previously reported:29–32 mouse anti-human HIF-1a (a67;
Novus Biologicals, Littleton, CO; 1:10 000), rabbit anti-mouse HIF-
2a (PM9, gift from Patrick Maxwell, Hammersmith Hospital,
Imperial College, London, UK; 1:10 000), rabbit anti-rat HO-1
(Stressgen, Victoria, Canada; 1:60 000), mouse anti-pimonidazole
(Hypoxyprobe; Natural Pharmacia International, Belmont, MA;
1:1000). Immunostaining was assessed semiquantitatively on a 0 to
4þ score basis: 0, no signals detectable; 1þ , staining in o5% of
tubular profiles or interstitial/endothelial cells; 2þ , 5–20%; 3þ ,
20–33%; and 4þ , 33–50%.
Statistics
Data are represented as means7s.e.m. Student’s t-test and multiple
comparisons with t-test post hoc analysis of variance were used as
indicated below, for the comparison of morphological, immuno-
histological and functional parameters. Statistical significance was
set at Po0.05.
ACKNOWLEDGMENTS
This work, formerly presented in part in abstract forms (J Am Soc
Nephrol 15:468A, 2004; J Am Soc Nephrol 16:402A, 2005), was
supported by the Russell Berrie Foundation and D-Cure, Diabetes
Care in Israel, by the Harvard Medical Faculty Physicians at Beth Israel
Deaconess Medical Center, Boston, MA, and by the Open Nephrology
Science Centre, Berlin, Germany.
REFERENCES
1. Hochachka PW, Buck LT, Doll CJ, Land C. Unifying theory of hypoxia
tolerance: molecular/metabolic defense and rescue mechanisms for
surviving oxygen lack. Proc Natl Acad Sci USA 1996; 93: 9493–9498.
2. Palm F, Cederberg J, Hansell P et al. Reactive oxygen species cause
diabetes-induced decrease in renal oxygen tension. Diabetologia 2003;
46: 1153–1160.
3. Ries M, Basseau F, Tyndal B et al. Renal diffusion and BOLD MRI in
experimental diabetic nephropathy. Blood oxygen level-dependent.
J Magn Reson Imaging 2003; 17: 104–113.
4. Eckardt KU, Bernhardt WM, Weidemann A et al. Role of hypoxia in the
pathogenesis of renal disease. Kidney Int Suppl 2005; 99: S46–S51.
5. Rosenberger C, Rosen S, Heyman SN. Intrarenal oxygenation in acute
renal failure. Clin Exp Pharmacol Physiol 2006; 33: 980–988.
6. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final
common pathway to end stage renal failure. J Am Soc Nephrol 2006; 17:
17–25.
7. Griffin MD, Bergstralhn EJ, Larson TS. Renal papillary necrosis––a
sixteen-year clinical experience. J Am Soc Nephrol 1995; 6: 248–256.
8. Rudnick MR, Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and
nonionic contrast media in 1196 patients: a randomized trial. The Iohexol
Cooperative Study. Kidney Int 1995; 47: 254–261.
9. McCullough PA, Wolyn R, Rocher LL et al. Acute renal failure after
coronary intervention: incidence, risk factors, and relationship to
mortality. Am J Med 1997; 103: 368–375.
10. Thakar CV, Arrigain S, Worley S et al. A clinical score to predict acute
renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16:
162–168.
11. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac
surgery. Clin J Am Soc Nephrol 2006; 1: 19–32.
12. Jones CA, Krolewski AS, Rogus J et al. Epidemic of end-stage renal disease
in people with diabetes in the United States population: do we know the
cause? Kidney Int 2005; 67: 1684–1691.
13. Maxwell PH. HIF-1’s relationship to oxygen: simple yet sophisticated.
Cell Cycle 2004; 3: 156–159.
14. Metzen E, Ratcliffe PJ. HIF hydroxylation and cellular oxygen sensing.
Biol Chem 2004; 385: 223–230.
15. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular
level. Physiology 2004; 19: 176–182.
16. Rosenberger C, Rosen S, Heyman S. Current understanding of HIF in renal
disease. Kidney Blood Press Res 2005; 28: 325–340.
17. Arjamaa O, Nikinmaa M. Oxygen-dependent diseases in the retina: role
of hypoxia-inducible factors. Exp Eye Res 2006; 83: 473–483.
18. Pouyssegur J, Mechta-Grigoriou F. Redox regulation of the
hypoxia-inducible factor. Biol Chem 2006; 387: 1337–1346.
19. Kaelin Jr WG. ROS: really involved in oxygen sensing. Cell Metab 2005; 1:
357–358.
20. Kietzmann T, Gorlach A. Reactive oxygen species in the control of
hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol
2005; 16: 474–486.
21. Zou AP, Cowley Jr AW. Reactive oxygen species and molecular regulation
of renal oxygenation. Acta Physiol Scand 2003; 179: 233–241.
22. Fridlyand LE, Philipson LH. Oxidative reactive species in cell injury:
mechanisms in diabetes mellitus and therapeutic approaches.
Ann N Y Acad Sci 2005; 1066: 136–151.
23. Li N, Yi FX, Spurrier JL et al. Production of superoxide through NADH
oxidase in thick ascending limb of Henle’s loop in rat kidney. Am J Physiol
Renal Physiol 2002; 282: F1111–F1119.
Kidney International (2008) 73, 34–42 41
C Rosenberger et al.: Hypoxia adaptation in rat kidney o r i g i n a l a r t i c l e
24. Zou AP, Li N, Cowley Jr AW. Production and actions of superoxide in the
renal medulla. Hypertension 2001; 37: 547–553.
25. Juncos R, Garvin JL. Superoxide enhances Na–K–2Cl cotransporter activity
in the thick ascending limb. Am J Physiol Renal Physiol 2005; 288:
F982–F987.
26. Yang ZZ, Zhang AY, Yi FX et al. Redox regulation of HIF-1alpha levels and
HO-1 expression in renal medullary interstitial cells. Am J Physiol Renal
Physiol 2003; 284: F1207–F1215.
27. Banday AA, Marwaha A, Tallam LS, Lokhandwala MF. Tempol reduces
oxidative stress, improves insulin sensitivity, decreases renal dopamine
D1 receptor hyperphosphorylation, and restores D1 receptor–G-protein
coupling and function in obese Zucker rats. Diabetes 2005; 54:
2219–2226.
28. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular–renal
system. Free Radic Biol Med 2005; 39: 1–25.
29. Rosenberger C, Heyman SN, Rosen S et al. Upregulation of HIF in
experimental acute renal failure: evidence for a protective transcriptional
response to hypoxia. Kidney Int 2005; 67: 531–542.
30. Rosenberger C, Griethe W, Gruber G et al. Cellular responses to hypoxia
after renal segmental infarction. Kidney Int 2003; 64: 874–886.
31. Rosenberger C, Rosen S, Shina A et al. Hypoxia inducible factors and
tubular cell survival in isolated perfused kidneys. Kidney Int 2006; 70:
60–70.
32. Rosenberger C, Mandriota S, Ju¨rgensen JS et al. Expression of hypoxia-
inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys.
J Am Soc Nephrol 2002; 13: 1721–1732.
33. Manotham K, Tanaka T, Ohse T et al. A biologic role of HIF-1 in the
renal medulla. Kidney Int 2005; 67: 1428–1439.
34. Prasad PV, Priatna A, Spokes K, Epstein FH. Changes in intrarenal
oxygenation as evaluated by BOLD MRI in a rat kidney model
for radiocontrast nephropathy. J Magn Reson Imaging 2001; 13:
744–747.
35. Kraynak AR, Storer RD, Jensen RD et al. Extent and persistence of
streptozotocin-induced DNA damage and cell proliferation in rat kidney
as determined by in vivo alkaline elution and BrdUrd labeling assays.
Toxicol Appl Pharmacol 1995; 35: 279–286.
36. Epstein FH, Silva P, Spokes K et al. Renal medullary Na–K-ATPase
and hypoxic injury in perfused rat kidneys. Kidney Int 1989; 36:
768–772.
37. Ward DT, Yau SK, Mee AP et al. Functional, molecular, and biochemical
characterization of streptozotocin-induced diabetes. J Am Soc Nephrol
2001; 12: 779–790.
38. Leyssac PP, Holstein-Rathlou N-H, Skott O. Renal blood flow, early
distal sodium, and plasma renin concentrations during osmotic diuresis.
Am J Physiol Regul Integr Comp Physiol 2000; 279: R1268–R1276.
39. Wald H, Scherzer P, Rasch R, Popovtzer MM. Renal tubular Na(+)–K(+)-
ATPase in diabetes mellitus: relationship to metabolic abnormality.
Am J Physiol 1993; 265: E96–E101.
40. Tsimaratos M, Coste TC, Djemli-Shipkolye A et al. Gamma-linolenic acid
restores renal medullary thick ascending limb Na(+), K(+)-ATPase activity
in diabetic rats. J Nutr 2001; 131: 3160–3165.
41. Haddad JJ, Harb HL. Cytokines and the regulation of the hypoxia-
inducible factor (HIF)-1alpha. Int Immunopharmacol 2005; 5: 461–483.
42. Zhou J, Fandrey J, Schu¨mann J et al. NO and TNF-alpha release from
activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1
cells. Am J Physiol 2003; 284: C439–C446.
43. Katavetin P, Miyata T, Inagi R et al. High glucose blunts vascular
endothelial growth factor response to hypoxia via the oxidative
stress-regulated hypoxia-inducible factor/hypoxia-responsible element
pathway. J Am Soc Nephrol 2006; 17: 1405–1413.
44. Yagil H, Barak A, Ben-Dor D et al. Nonproteinuric diabetes-associated
nephropathy in the Cohen rat model of type 2 diabetes. Diabetes 2005;
54: 1487–1496.
45. Weksler-Zangen S, Yagil H, Zangen DH et al. The newly inbred cohen
diabetic rat. A non-obese normolipidemic genetic model of diet-induced
type 2 diabetes expressing sex differences. Diabetes 2001; 50: 2521–2529.
46. Li J, Chen YJ, Quilley J. Effect of tempol on renal cyclooxygenase
expression and activity in experimental diabetes in the rat. J Pharmacol
Exp Ther 2005; 314: 818–824.
47. Nassar T, Kadery B, Lotan H et al. Effects of the superoxide dismutase-
mimetic compound tempol on endothelial dysfunction in streptozotocin-
induced diabetic rats. Eur J Pharmacol 2002; 436: 111–118.
48. Lien EL, Garsky VM. Route of administration as a factor in the selectivity of
hormone suppression of a somatostatin analogue in rats. Horm Metab Res
1981; 13: 675–678.
49. Goldfarb M, Rosenberger C, Abassi Z et al. Acute-on-chronic renal failure
in the rat: functional compensation and hypoxia tolerance. Am J Nephrol
2006; 26: 22–33.
50. Franko AJ, Chapmann JD. Binding of 14C-misonidazole to hypoxic cells
in V79 spheroids. Br J Cancer 1982; 45: 694–699.
51. Arteel GE, Thurmann RG, Raleigh JA. Reductive metabolism of the
hypoxia marker pimonidazole is regulated by oxygen tension
independent of the pyridine nucleotide redox state. Eur J Biochem 1998;
253: 743–750.
42 Kidney International (2008) 73, 34–42
o r i g i n a l a r t i c l e C Rosenberger et al.: Hypoxia adaptation in rat kidney
